Cargando…

The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin

Chemical castration, that is the reduction of circulating testosterone concentrations to castrate levels by administration of a GnRH‐agonist implant, is a popular alternative to surgical castration in male dogs. Detailed information concerning the pituitary‐testicular axis following administration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Spruijt, Annemarie, Kooistra, Hans, Oei, Christine, Vinke, Claudia, Schaefers‐Okkens, Auke, De Gier, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086795/
https://www.ncbi.nlm.nih.gov/pubmed/36165853
http://dx.doi.org/10.1111/rda.14266
_version_ 1785022220501778432
author Spruijt, Annemarie
Kooistra, Hans
Oei, Christine
Vinke, Claudia
Schaefers‐Okkens, Auke
De Gier, Jeffrey
author_facet Spruijt, Annemarie
Kooistra, Hans
Oei, Christine
Vinke, Claudia
Schaefers‐Okkens, Auke
De Gier, Jeffrey
author_sort Spruijt, Annemarie
collection PubMed
description Chemical castration, that is the reduction of circulating testosterone concentrations to castrate levels by administration of a GnRH‐agonist implant, is a popular alternative to surgical castration in male dogs. Detailed information concerning the pituitary‐testicular axis following administration of a GnRH‐agonist implant is still scarce. Therefore, GnRH‐stimulation tests were performed in male dogs, prior to and after surgical and chemical castration. This approach also allowed us to determine plasma concentrations of testosterone and oestradiol in intact male dogs for future reference and to directly compare the effects of surgical and chemical castration on the pituitary‐testicular axis. In intact male dogs (n = 42) of different breeds GnRH administration induced increased plasma LH, FSH, oestradiol and testosterone concentrations. After surgical castration basal and GnRH‐induced plasma FSH and LH concentrations increased pronouncedly. Additionally, basal and GnRH‐induced plasma oestradiol and testosterone concentrations decreased after surgical castration. After chemical castration, with a slow‐release implant containing the GnRH‐agonist deslorelin, plasma LH and FSH concentrations were lower than prior to castration and lower compared with the same interval after surgical castration. Consequently, plasma oestradiol and testosterone concentrations were lowered to values similar to those after surgical castration. GnRH administration to the chemically castrated male dogs induced a significant increase in the plasma concentrations of LH, but not of FSH. In conclusion, after administration of the deslorelin implant, the plasma concentrations of oestradiol and testosterone did not differ significantly from the surgically castrated animals. After GnRH‐stimulation, none of the dogs went to pre‐treatment testosterone levels. However, at the moment of assessment at 4,4 months (mean 133 days ± SEM 4 days), the pituitary gonadotrophs were responsive to GnRH in implanted dogs. The increase of LH, but not of FSH, following GnRH administration indicates a differential regulation of the release of these gonadotrophins, which needs to be considered when GnRH‐stimulation tests are performed in implanted dogs.
format Online
Article
Text
id pubmed-10086795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100867952023-04-12 The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin Spruijt, Annemarie Kooistra, Hans Oei, Christine Vinke, Claudia Schaefers‐Okkens, Auke De Gier, Jeffrey Reprod Domest Anim Original Articles Chemical castration, that is the reduction of circulating testosterone concentrations to castrate levels by administration of a GnRH‐agonist implant, is a popular alternative to surgical castration in male dogs. Detailed information concerning the pituitary‐testicular axis following administration of a GnRH‐agonist implant is still scarce. Therefore, GnRH‐stimulation tests were performed in male dogs, prior to and after surgical and chemical castration. This approach also allowed us to determine plasma concentrations of testosterone and oestradiol in intact male dogs for future reference and to directly compare the effects of surgical and chemical castration on the pituitary‐testicular axis. In intact male dogs (n = 42) of different breeds GnRH administration induced increased plasma LH, FSH, oestradiol and testosterone concentrations. After surgical castration basal and GnRH‐induced plasma FSH and LH concentrations increased pronouncedly. Additionally, basal and GnRH‐induced plasma oestradiol and testosterone concentrations decreased after surgical castration. After chemical castration, with a slow‐release implant containing the GnRH‐agonist deslorelin, plasma LH and FSH concentrations were lower than prior to castration and lower compared with the same interval after surgical castration. Consequently, plasma oestradiol and testosterone concentrations were lowered to values similar to those after surgical castration. GnRH administration to the chemically castrated male dogs induced a significant increase in the plasma concentrations of LH, but not of FSH. In conclusion, after administration of the deslorelin implant, the plasma concentrations of oestradiol and testosterone did not differ significantly from the surgically castrated animals. After GnRH‐stimulation, none of the dogs went to pre‐treatment testosterone levels. However, at the moment of assessment at 4,4 months (mean 133 days ± SEM 4 days), the pituitary gonadotrophs were responsive to GnRH in implanted dogs. The increase of LH, but not of FSH, following GnRH administration indicates a differential regulation of the release of these gonadotrophins, which needs to be considered when GnRH‐stimulation tests are performed in implanted dogs. John Wiley and Sons Inc. 2022-09-27 2023-01 /pmc/articles/PMC10086795/ /pubmed/36165853 http://dx.doi.org/10.1111/rda.14266 Text en © 2022 The Authors. Reproduction in Domestic Animals published by Wiley‐VCH GmbH. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Spruijt, Annemarie
Kooistra, Hans
Oei, Christine
Vinke, Claudia
Schaefers‐Okkens, Auke
De Gier, Jeffrey
The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin
title The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin
title_full The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin
title_fullStr The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin
title_full_unstemmed The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin
title_short The function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the GnRH‐agonist deslorelin
title_sort function of the pituitary‐testicular axis in dogs prior to and following surgical or chemical castration with the gnrh‐agonist deslorelin
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086795/
https://www.ncbi.nlm.nih.gov/pubmed/36165853
http://dx.doi.org/10.1111/rda.14266
work_keys_str_mv AT spruijtannemarie thefunctionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT kooistrahans thefunctionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT oeichristine thefunctionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT vinkeclaudia thefunctionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT schaefersokkensauke thefunctionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT degierjeffrey thefunctionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT spruijtannemarie functionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT kooistrahans functionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT oeichristine functionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT vinkeclaudia functionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT schaefersokkensauke functionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin
AT degierjeffrey functionofthepituitarytesticularaxisindogspriortoandfollowingsurgicalorchemicalcastrationwiththegnrhagonistdeslorelin